To Look or Not to Look at the Needle During Vaccination

October 23, 2016 updated by: Anna Taddio, University of Toronto

To Look or Not to Look? Pilot Study of the Effectiveness of a Simple Psychological Intervention in Reducing Vaccination Pain and Fear in Adult

It is common for people to advise individuals undergoing vaccination to look away from the needle to make them hurt less and be less scary. However, this advice is not backed up by research evidence. the purpose of this study is to learn about how looking away vs. looking at the needle during vaccination makes people feel. People will be randomized to 1 of 2 groups: look at the needle, look away. Then they will undergo vaccination and report on pain and fear experienced.

Study Overview

Detailed Description

It is common for people to advise individuals undergoing vaccination to look away from the needle to make them hurt less and be less scary. However, this advice is not backed up by experimental research evidence. It is possible that looking away acts as a distraction and takes attention away from the needle, thus reducing pain. However, it is also possible that looking at the needle is better because it prevents people's imaginations from making them think it is worse than it actually is. To our knowledge, this is the first first randomized study to examine the effect of looking away vs. looking at the needle on pain and fear experienced during vaccinations. Adult university students undergoing routine flu vaccination will be included.

Study Type

Interventional

Enrollment (Anticipated)

160

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S 3M2
        • Recruiting
        • Anna Taddio
        • Principal Investigator:
          • Pamela Simmons, RN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • undergraduate and graduate students at the University of Toronto's Leslie Dan Faculty of Pharmacy undergoing flu vaccination

Exclusion Criteria:

  • less than 18 years of age or prior participation in the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Look away and prefer to look
Participant who is self-identified as preferring to look at the needle is randomized to look away from the needle during vaccination
Participant looks away from the needle during vaccination
Active Comparator: Look at needle and prefer to look
Participant who is self-identified as preferring to look at the needle is randomized to look at the needle during vaccination
Participant looks at the needle during vaccination
Experimental: Look away and prefer to look away
Participant who is self-identified as preferring to look away from the needle is randomized to look away from the needle during vaccination
Participant looks away from the needle during vaccination
Active Comparator: Look at needle and prefer to look away
Participant who is self-identified as preferring to look away from the needle is randomized to look at the needle during vaccination
Participant looks at the needle during vaccination

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: immediately after vaccination (<5 minutes)
self-reported pain assessed after vaccination using a numerical rating scale (0-10)
immediately after vaccination (<5 minutes)
Fear
Time Frame: immediately after vaccination (<5 minutes)
self-reported fear assessed after vaccination using a numerical rating scale (0-10)
immediately after vaccination (<5 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: before vaccination (1 day to 4 weeks)
percentage of people eligible that participate
before vaccination (1 day to 4 weeks)
Feasibility of recruitment of subjects in the 2 study strata (i.e., preference to look or not look)
Time Frame: immediately before vaccination (<5 minutes)
percentage of individuals that prefer to look or not look at baseline
immediately before vaccination (<5 minutes)
Duration of appointment
Time Frame: immediately after vaccination
Amount of time taken for appointment as per clock
immediately after vaccination
Attrition of participants
Time Frame: immediately after vaccination
number of participants that are lost/drop-out of study
immediately after vaccination
Preferences of participants
Time Frame: immediately after vaccination (<5 minutes)
participant preferences about interventions according to questionnaire
immediately after vaccination (<5 minutes)
Fidelity of intervention
Time Frame: During vaccination
Compliance with instruction to look at the needle or look away, according to checklist
During vaccination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2016

Primary Completion (Anticipated)

March 1, 2017

Study Completion (Anticipated)

March 1, 2017

Study Registration Dates

First Submitted

October 13, 2016

First Submitted That Met QC Criteria

October 14, 2016

First Posted (Estimate)

October 18, 2016

Study Record Updates

Last Update Posted (Estimate)

October 25, 2016

Last Update Submitted That Met QC Criteria

October 23, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 33392

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaccination

Clinical Trials on Look away from the needle

Subscribe